Insider Trading History of Suliman Shehnaaz

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Suliman Shehnaaz since 2021. This trader's CIK number is 1713070. At the time of last reporting, Suliman Shehnaaz was the Officer of Ultragenyx Pharmaceutical Inc.. (stock ticker symbol RARE). Also see all insider trading activities at Ultragenyx Pharmaceutical Inc..

Note that in the past SULIMAN SHEHNAAZ also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Alector, Inc. (ALEC) by Suliman Shehnaaz

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 ALEC 0 $0 300,000 $6,700,725 300,000 $4,906,875

Yearly summary of insider trading at Ultragenyx Pharmaceutical Inc. (RARE) by Suliman Shehnaaz

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2026 RARE 0 $0 5,740 $144,188 0 $0


Insider trading activities at 2 companies by Suliman Shehnaaz:

1. Alector, Inc. (ALEC)

2. Ultragenyx Pharmaceutical Inc. (RARE)

Table 1. Insider trading of Alector, Inc. (ALEC) by Suliman Shehnaaz

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-12-10 ALEC Option Ex 75,000 17.23 1,292,250
2021-12-13 ALEC Sale 75,000 21.44 1,608,300
2021-12-13 ALEC Option Ex 75,000 17.23 1,292,250
2021-12-10 ALEC Sale 75,000 22.01 1,650,750
2021-12-08 ALEC Sale 75,000 22.79 1,708,875
2021-12-09 ALEC Option Ex 75,000 17.23 1,292,250
2021-12-08 ALEC Option Ex 75,000 13.73 1,030,125
2021-12-09 ALEC Sale 75,000 23.10 1,732,800

Table 2. Insider trading of Ultragenyx Pharmaceutical Inc. (RARE) by Suliman Shehnaaz

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2026-05-18 RARE Sale 5,740 25.12 144,188

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Suliman Shehnaaz (Officer of Ultragenyx Pharmaceutical Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.